With the potential for breakthroughs in the lab to revolutionize medicine, Glencoe Software and Aridhia Informatics are combining resources to advance new technology products to support personalized treatment development and better patient care.
Dundee, Scotland-based Aridhia is making a "major investment" of an undisclosed amount in Glencoe, which is headquartered in Seattle. Glencoe develops software products with open-source technology from the Open Microscopy Environment (OME) and will bring to the partnership know-how in "managing, sharing and publishing large scientific datasets generated in laboratories around the world," the company said in a release. For its part, Aridhia plans to complement those capabilities with its expertise in "accessing, storing and analyzing healthcare information."
"OME and Glencoe Software are particularly excited about this partnership," Jason Swedlow, president of Glencoe Software and co-founder of OME. "We look forward to working with the Aridhia Informatics team to develop new tools for the life sciences and clinical data markets. The challenge is huge, but the potential benefit for biomedical research and patient outcomes is enormous."
While their businesses are incorporated in different countries, Aridhia and Glencoe were both formed with technology from the University of Dundee in Scotland.
- here's the release
- see the news in the Edinburgh Evening News
- and the report in GenomeWeb
NextDocs opens door to VC with $10.3M funding
PharmaPros teams up with Soltex, extends pharma reach